Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis

被引:13
|
作者
Gander-Bui, Hang Thi Thuy [1 ,2 ]
Schlaurofli, Joeurolle [1 ]
Baumgartner, Johanna [1 ,2 ]
Walthert, Sabrina [1 ]
Genitsch, Vera [3 ]
van Geest, Geert [4 ]
Galvan, Jose A. [3 ]
Cardozo, Carmen [3 ]
Martinez, Cristina Graham [3 ]
Grans, Mona [5 ]
Muth, Sabine [5 ]
Bruggmann, Remy [4 ]
Probst, Hans Christian [5 ]
Gabay, Cem [6 ]
Freigang, Stefan [1 ]
机构
[1] Univ Bern, Inst Tissue Med & Pathol, Div Expt Pathol, CH-3008 Bern, Switzerland
[2] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland
[3] Univ Bern, Inst Tissue Med & Pathol, CH-3008 Bern, Switzerland
[4] Univ Bern, Interfac Bioinformat Unit, CH-3012 Bern, Switzerland
[5] Univ Med Ctr Mainz, Inst Immunol, D-55131 Mainz, Germany
[6] Univ Hosp Geneva, Dept Med, Div Rheumatol, CH-1211 Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
HOST-DEFENSE; NLRP3; INFLAMMASOME; DENDRITIC CELLS; IMMUNITY; INNATE; RECOGNITION; INTERFERONS; HOMEOSTASIS; INFECTIONS; DEFICIENCY;
D O I
10.1016/j.immuni.2023.06.023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invasive fungal infections are associated with high mortality rates, and the lack of efficient treatment options emphasizes an urgency to identify underlying disease mechanisms. We report that disseminated Candida albicans infection is facilitated by interleukin-1 receptor antagonist (IL-1Ra) secreted from macrophages in two temporally and spatially distinct waves. Splenic CD169+ macrophages release IL-1Ra into the bloodstream, impeding early neutrophil recruitment. IL-1Ra secreted by monocyte-derived tissue macrophages further impairs pathogen containment. Therapeutic IL-1Ra neutralization restored the functional competence of neutrophils, corrected maladapted hyper-inflammation, and eradicated the otherwise lethal infection. Conversely, augmentation of macrophage-secreted IL-1Ra by type I interferon severely aggravated disease mortality. Our study uncovers how a fundamental immunoregulatory mechanism mediates the high disease susceptibility to invasive candidiasis. Furthermore, interferon-stimulated IL-1Ra secretion may exacerbate fungal dissemination in human patients with secondary candidemia. Macrophage-secreted IL-1Ra should be considered as an additional biomarker and potential therapeutic target in severe systemic candidiasis.
引用
收藏
页码:1743 / +
页数:28
相关论文
共 50 条
  • [12] Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients
    Intke, Carina
    Korpelainen, Sini
    Hamalainen, Sari
    Vans, Matti
    Koivula, Irma
    Jantunen, Esa
    Pulkki, Kari
    Juutilainen, Auni
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (05) : 691 - 698
  • [13] USE OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST FOR SUSPECTED SEPSIS WITH HYPERINFLAMMATION IN CHILDREN
    Badheka, Aditya
    Cifra, Christina
    Vijayakumar, Niranjan
    Lilitwat, Weerapong
    Newell, Elizabeth
    CRITICAL CARE MEDICINE, 2020, 48
  • [14] INTERLEUKIN-1 ACTIVATION OF HUMAN GRANULOCYTE ACTIVITY AGAINST CANDIDA-ALBICANS
    WANG, M
    BLANCHARD, DK
    FRIEDMAN, H
    SHIOTSUKI, K
    DJEU, JY
    LYMPHOKINE RESEARCH, 1988, 7 (03): : 339 - 339
  • [15] Elevated interleukin-1 receptor antagonist levels in pediatric sepsis syndrome
    Samson, LM
    Allen, UD
    Creery, WD
    DiazMitoma, F
    Singh, RN
    JOURNAL OF PEDIATRICS, 1997, 131 (04): : 587 - 591
  • [16] PROTECTION OF NEUTROPENIC MICE FROM LETHAL CANDIDA-ALBICANS INFECTION BY RECOMBINANT INTERLEUKIN-1
    VANTWOUT, JW
    VANDERMEER, JWM
    BARZA, M
    DINARELLO, CA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (07) : 1143 - 1146
  • [17] Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo
    Qian, Lan
    Xiang, Di
    Zhang, Jing
    Zhu, Shunying
    Gao, Jin
    Wang, Xia
    Gao, Jing
    Zhang, Yang
    Shen, Jiaqing
    Yu, Yan
    Han, Wei
    Wu, Mingyuan
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (02) : 108 - 115
  • [18] Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis
    Arnalich, F
    López-Maderuelo, D
    Codoceo, R
    Lopez, J
    Solis-Garrido, LM
    Capiscol, C
    Fernandez-Capitán, C
    Madero, R
    Montiel, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (02): : 331 - 336
  • [19] INCREASED PLASMA-CONCENTRATIONS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN NEONATAL SEPSIS
    DEBONT, ESJM
    DELEIJ, LHFM
    OKKEN, A
    BAARSMA, R
    KIMPEN, JLL
    PEDIATRIC RESEARCH, 1995, 37 (05) : 626 - 629
  • [20] INTERLEUKIN-1 RECEPTOR ANTAGONIST ATTENUATES MUSCLE PROTEIN WASTING DURING SEPSIS
    VARY, TC
    COONEY, R
    OWENS, E
    JURASINSKI, C
    GRAY, K
    VANNICE, J
    FASEB JOURNAL, 1994, 8 (04): : A428 - A428